BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17706830)

  • 21. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
    Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
    Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.
    Kikuchi S; Takayama K
    Int J Pharm; 2010 Feb; 386(1-2):149-55. PubMed ID: 19922778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the diffusion coefficient of water vapor through glassy HPMC films at different environmental conditions using the free volume additivity approach.
    Laksmana FL; Hartman Kok PJ; Vromans H; Van der Voort Maarschalk K
    Eur J Pharm Sci; 2009 Jul; 37(5):545-54. PubMed ID: 19409985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the behavior of HPMC/Theophylline matrices for controlled drug delivery.
    Barba AA; d'Amore M; Cascone S; Chirico S; Lamberti G; Titomanlio G
    J Pharm Sci; 2009 Nov; 98(11):4100-10. PubMed ID: 19226633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A predictive model for the release of slightly water-soluble drugs from HPMC matrices.
    Fu XC; Wang GP; Wang YH; Liang WQ
    Pharmazie; 2004 Aug; 59(8):624-6. PubMed ID: 15378852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and evaluation of delayed-onset extended-release tablets of metoprolol tartrate using hydrophilic-swellable polymers.
    Dadarwal SC; Madan S; Agrawal SS
    Acta Pharm; 2012 Mar; 62(1):105-14. PubMed ID: 22472453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
    Ferrero C; Massuelle D; Doelker E
    J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST; Patel LD; Patel DM
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compression and compaction properties of plasticised high molecular weight hydroxypropylmethylcellulose (HPMC) as a hydrophilic matrix carrier.
    Hardy IJ; Cook WG; Melia CD
    Int J Pharm; 2006 Mar; 311(1-2):26-32. PubMed ID: 16431049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices.
    Ghori MU; Ginting G; Smith AM; Conway BR
    Int J Pharm; 2014 Apr; 465(1-2):405-12. PubMed ID: 24560637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and evaluation of a gastroretentive dosage form of labetalol hydrochloride.
    Garse H; Vij M; Yamgar M; Kadam V; Hirlekar R
    Arch Pharm Res; 2010 Mar; 33(3):405-10. PubMed ID: 20361305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined approach of FTIR imaging and conventional dissolution tests applied to drug release.
    van der Weerd J; Kazarian SG
    J Control Release; 2004 Aug; 98(2):295-305. PubMed ID: 15262420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2008 Mar; 351(1-2):61-73. PubMed ID: 17996408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
    Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A
    J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible application of magnetic resonance imaging for pharmaceutical research.
    Kowalczuk J; Tritt-Goc J
    Eur J Pharm Sci; 2011 Mar; 42(4):354-64. PubMed ID: 21195171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. III. Critical use of thermodynamic parameters of activation for modeling the water penetration and drug release processes.
    Ferrero C; Massuelle D; Jeannerat D; Doelker E
    J Control Release; 2013 Sep; 170(2):175-82. PubMed ID: 23727289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.